The Lycium ruthenicum Murr variety of goji berry exhibits a stronger antioxidant activity and antiproliferative effect on cancer cells compared to Lycium barbarum L.
Experimental Study Anticancer Antioxidant Cancer
For methodology, the researchers examined the phytochemical profiles of two different varieties of goji berries: Lycium ruthenicum Murr (LRM) and Lycium barbarum L. (LB). They then evaluated the antioxidant activity of these varieties using multiple assays. For the assessments of antiproliferative effect, they tested the ability of high dose LRM and LB supplementation to interfere with cell cycle progression and induce apoptosis in MDA cells, a specific type of cancer cells.
In the discussion of results, it was found that LRM overpowered LB in both antioxidant activity and antiproliferative mechanism, owing to its higher total phenolics and flavonoids. LB, while it was higher in VE and carotenoids, had less remarkable effects on cell cycle interference and apoptosis induction. Both LRM and LB triggered the activation of a proliferation-related signaling pathway; however, LB did not manage to lower the levels of two specific proteins which indicates a weaker antiproliferative effect. Despite these differences, both varieties were considered potential assets for managing the growth of cancerous cells and enhancing human health.
View Article